Cargando…
Review of investigational drugs for coronavirus disease 2019
In December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became evident in Wuhan, China, and then spread rapidly worldwide. Numerous drugs and vaccines are under clinical trial pipeline for investigation against coronavirus disease 2019 (COVID-19) infection. The aim of this...
Autores principales: | Sharma, Dhruva, Sharma, Neha, Sharma, Preksha, Subramaniam, Ganapathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933614/ https://www.ncbi.nlm.nih.gov/pubmed/33688540 http://dx.doi.org/10.4103/jehp.jehp_457_20 |
Ejemplares similares
-
Insight into Noninvasive Radiological Modalities to Detect Heart Transplant Rejection
por: Sharma, Dhruva, et al.
Publicado: (2022) -
A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations
por: Sharma, Preksha, et al.
Publicado: (2022) -
The starfish story and lung transplantation for COVID-19
por: Sharma, Dhruva, et al.
Publicado: (2020) -
Stroke in Coronavirus Disease 2019: A Systematic Review
por: Bhatia, Rohit, et al.
Publicado: (2020) -
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
por: Louchet, Margaux, et al.
Publicado: (2020)